Literature DB >> 28658373

Mortality due to cirrhosis, liver cancer, and disorders attributed to alcohol use: Global Burden of Disease in Brazil, 1990 and 2015.

Ana Paula Souto Melo1, Elisabeth Barboza França2, Deborah Carvalho Malta3, Leila Posenato Garcia4, Meghan Mooney5, Mohsen Naghavi5.   

Abstract

INTRODUCTION: : Alcohol use is one of the main preventable risk factors affecting mortality and premature disability.
OBJECTIVE: : To describe the estimates of mortality and years of life lost as a result of premature death (YLL) due to cirrhosis, liver cancer, and disorders attributed to alcohol use in Brazil and its federated units in 1990 and 2015.
METHODS: : Descriptive study using data from the Global Burden of Disease Study (2015) and the Mortality Information System (SIM). Statistical models were used to obtain corrected mortality estimates for selected causes. Rates were standardized by age.
RESULTS: : In 1990, 16,226 deaths were estimated for the three conditions (17.0/100 thousand inhabitants), while in 2015 there were 28,337 deaths (15.7/100 thousand inhabitants). There was a reduction in mortality (per 100 thousand) due to cirrhosis (from 11.4 to 9.5), stability in mortality rates related to liver cancer (1.5 and 1.9), and stability in mortality rates caused by alcohol use disorders (4.1 and 4.3). Mortality rates were 5.1 times higher among men, and the five states with the highest mortality rates and YLL were from the Northeast Region: Sergipe, Ceará, Pernambuco, Paraíba, and Alagoas. Mortality and YLL rates for the three conditions studied increased in the ranking of causes of death in both sexes, with the exception of cirrhosis in the female population.
CONCLUSION: : The three conditions studied are responsible for a significant burden of premature mortality in Brazil, especially among men and residents of the northeast region. These results reinforce the urgent need for public policies that address harmful alcohol consumption in Brazil.

Entities:  

Mesh:

Year:  2017        PMID: 28658373     DOI: 10.1590/1980-5497201700050006

Source DB:  PubMed          Journal:  Rev Bras Epidemiol        ISSN: 1415-790X


  6 in total

1.  Network Pharmacology and Bioinformatics Approach Reveals the Multi-Target Pharmacological Mechanism of Fumaria indica in the Treatment of Liver Cancer.

Authors:  Sara Batool; Muhammad Rizwan Javed; Sidra Aslam; Fatima Noor; Hafiz Muhammad Faizan Javed; Riffat Seemab; Abdur Rehman; Muhammad Farhan Aslam; Bilal Ahamad Paray; Aneela Gulnaz
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-25

2.  A Network Pharmacology-Based Study on the Hepatoprotective Effect of Fructus Schisandrae.

Authors:  Ming Hong; Yongsheng Zhang; Sha Li; Hor Yue Tan; Ning Wang; Shuzhen Mu; Xiaojiang Hao; Yibin Feng
Journal:  Molecules       Date:  2017-09-28       Impact factor: 4.411

3.  A time series analysis of detection and mortality of hepatitis C in Brazil, 2008-2018.

Authors:  Rodrigo José Videres Cordeiro de Brito; Leonardo Feitosa da Silva; Márcio Bezerra Santos; Patrícia Muniz Mendes Freire de Moura; Carlos Dornels Freire de Souza; Rodrigo Feliciano do Carmo
Journal:  BMC Infect Dis       Date:  2022-01-24       Impact factor: 3.090

4.  Regional differences and temporal trend analysis of Hepatitis B in Brazil.

Authors:  Giuliano Grandi; Luis Fernandez Lopez; Marcelo Nascimento Burattini
Journal:  BMC Public Health       Date:  2022-10-17       Impact factor: 4.135

5.  The burden of Neglected Tropical Diseases in Brazil, 1990-2016: A subnational analysis from the Global Burden of Disease Study 2016.

Authors:  Francisco Rogerlândio Martins-Melo; Mariângela Carneiro; Alberto Novaes Ramos; Jorg Heukelbach; Antonio Luiz Pinho Ribeiro; Guilherme Loureiro Werneck
Journal:  PLoS Negl Trop Dis       Date:  2018-06-04

6.  The burden of suicide in Brazil: findings from the Global Burden of Disease Study 2019.

Authors:  Cecília Silva Costa Bonadiman; Mohsen Naghavi; Ana Paula Souto Melo
Journal:  Rev Soc Bras Med Trop       Date:  2022-01-28       Impact factor: 1.581

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.